3.23 USD
↗ 0.04 (1.25%)AT CLOSE (03:59 PM EDT)
Mannkind Corporation
MNKDNASDAQ • USD
3.23
↘ 0.00 (0.15%)
POST MARKET (AS OF 05:18 PM EDT)
Post Market
AS OF 05:18 PM EDT
3.23
↘ 0.00 (0.15%)
Market: OPEN
Mannkind Corporation (MNKD) trades at $3.23 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (64.9%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place MNKD at a fair price relative to peers.
Technical & fundamental data as of Oct 26, 2026.
Open?$3.21
High?$3.28
Low?$3.15
Prev. Close?$3.19
Volume?2.0M
Avg. Volume?4.8M
VWAP?$3.20
Rel. Volume?0.41x
Bid / Ask
Bid?$2.77 × 100
Ask?$3.71 × 100
Spread?$0.94
Midpoint?$3.24
Valuation & Ratios
Market Cap?1.0B
Shares Out?321.5M
Float?311.9M
Float %?97.0%
P/E Ratio?N/A
P/B Ratio?-15.26
EPS?-$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
Employees
592
Market Cap
1.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2004-07-28
Address
1 CASPER STREET
DANBURY, CT 06810
Phone: 818-661-5000
DANBURY, CT 06810
Phone: 818-661-5000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?69
Short Sent.?60
Piotroski F-Score?2/9Weak
Altman Z-Score?-4.67Distress
Confidence?55%Low
Short InterestHigh
Short % of Float?8.17%Elevated
Short Interest?25.5M
Days to Cover?5.1
Free Float311.9M
Avg Daily Volume5.0M
Settlement Date2026-10-15
Financial Health
Current Ratio?1.72Adequate
Quick Ratio?1.41Adequate
Cash Ratio?0.37Low
Debt/Equity?-7.22Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score75/100
P/E?N/A▾
P/B?-15.26CHEAP▾
S&P97
P/S?2.61CHEAP▾
Peers100
S&P56
P/FCF?N/A▾
EV/EBITDA?51.8HIGH▾
Peers100
S&P3
EV/Sales?3.70FAIR▾
Peers100
S&P51
Returns & Efficiency
ROE?64.9%STRONG▾
Peers50
S&P93
ROA?-6.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-18135000
Enterprise Value?$1.5B
Fundamentals ratios updated end of day